The Future Of RNA: Clinical Strategy And Global Opportunity

In this podcast episode, Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full-service clinical CRO dedicated to accelerating the development of advanced and novel therapeutics, offers a sharp and timely look at the state of RNA therapeutics and shares how innovation in delivery technologies, regulatory strategy, and partnership models is shaping the next generation of RNA-based medicines. With Novotech’s deep experience in the space, Tom provides actionable insights for biotech leaders looking to position their RNA programs for long-term success.